All News #Library
Others
Aurion Biotech doses first patients in phase 3 ASTRA study
08 Apr 2026 //
BUSINESSWIRE
Aurion Announces First Canadian Subject Dosed in Phase 1 / 2 Clinical Trial
28 Mar 2024 //
BUSINESSWIRE

Market Place
Sourcing Support